Literature DB >> 3897422

A macrophage-derived factor that inhibits the production and action of interleukin 2.

T Krakauer.   

Abstract

The human monocytic leukemia cell line THP-1 produces an immunosuppressive factor that inhibits interleukin 1 (IL-1)-dependent proliferation of mouse thymocytes as well as the mitogenic effects of concanavalin A (Con A) and phytohemagglutinin (PHA) on human peripheral blood mononuclear cells. The mechanism of action of this factor includes interference with both the production of interleukin 2 (IL-2) and its effects on target cells. Thus, the suppressor abrogates the proliferation of an IL-2-dependent cytotoxic T cell line (CTLL), but not of IL-2 independent cells like the L929 fibroblasts or the EL4 T lymphoma and U937 histiocytic lymphoma lines. It also suppresses IL-2 production by human peripheral blood enriched T cells and mouse splenocytes. The mediator has a molecular weight of 60,000-70,000 dalton, as determined by gel filtration chromatography, is heat labile, and is sensitive to trypsin, chymotrypsin, and protease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3897422     DOI: 10.1002/jlb.38.3.429

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  5 in total

1.  Inhibition of bleomycin-induced pulmonary fibrosis by nordihydroguaiaretic acid. The role of alveolar macrophage activation and mediator production.

Authors:  S H Phan; S L Kunkel
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

2.  Increased polyamines may downregulate interleukin 2 production in rheumatoid arthritis.

Authors:  E Flescher; T L Bowlin; A Ballester; R Houk; N Talal
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

3.  Clostridium perfringens enterotoxin lacks superantigenic activity but induces an interleukin-6 response from human peripheral blood mononuclear cells.

Authors:  T Krakauer; B Fleischer; D L Stevens; B A McClane; B G Stiles
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  Multiple sclerosis: effect of myelin basic protein on interleukin 1, interleukin 2 production and interleukin 2 receptor expression in vitro.

Authors:  K Selmaj; Z Nowak; H Tchórzewski
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

5.  Increased soluble interleukin-2 receptor concentration in plasma predicts a decreased cellular response to IL-2.

Authors:  R Gooding; P Riches; G Dadian; J Moore; M Gore
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.